Japan – Third Japanese company begins COVID-19 vaccine trials

Japan’s KM Biologics Co said on Monday it had started a human trial for its COVID-19 vaccine, becoming the country’s third candidate to advance to clinical trials.

The first volunteer was injected with the inactivated virus vaccine known as KD-414, the company said in a release…